#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acquired haemophilia Raynaud's phenomenon Breast angiosarcoma Glioma Lymphangiosarcoma Sickle cell anaemia Myelin oligodendrocyte glycoprotein antibody-associated disease Crigler-Najjar syndrome Glycogen storage disease type V Angiosarcoma recurrent Acute hepatic failure Thrombocytopenia Hypergammaglobulinaemia benign monoclonal Pyruvate kinase deficiency anaemia Chronic graft versus host disease in skin More trials…

    Learn about Rare Diseases

    Isodicentric chromosome 15 syndrome – Diagnostics Rhabdoid tumour – Trials in Disease Alport’s syndrome – Life with Disease Skin angiosarcoma Turner’s syndrome – Trials in Disease Pelizaeus-Merzbacher disease Breast angiosarcoma – Trials in Disease Lennox-Gastaut syndrome – Treatment Marfan’s syndrome – Diagnostics Mantle cell lymphoma stage III – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iti-1284 Axatilimab Sulfamethoxazole Kyv-101 Delandistrogene Moxeparvovec ZALFERMIN CANNABINOL Obexelimab Neob Pegfilgrastim Tpst-1120 Botaretigene Sparoparvovec Nebivolol Oms906 Sodium Ascorbate Valiltramiprosate FOSMANOGEPIX Rbl012.2 Lorundrostat Quc398 More therapies…

    Learn about Your Condition

    Tetanus HER2 positive breast cancer Fibrosarcoma metastatic Adrenal insufficiency Anal fissure Cough Transitional cell carcinoma EGFR gene mutation Heparin resistance Plasma cell myeloma Mitral valve prolapse Thalassaemia alpha Muscle strain Atrial septal defect Testicular germ cell tumour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on How Evolocumab and Atorvastatin Affect Cholesterol and Bile Acid Metabolism in Healthy Volunteers

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Evolocumab
    • Atorvastatin
    Sweden

  • Study on the Effects of Alglucosidase Alfa Enzyme Therapy in Children and Adults with Pompe Disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Investigated Drugs:
    • Alglucosidase Alfa
    The Netherlands

  • Study on the Immune Response and Safety of a Second Dose of Investigational Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Varicella
    Investigated Drugs:
    • GSKVX000000025896
    • VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED)
    • VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS
    Denmark Norway

  • Study on the Effects of Apixaban Absorption in Patients Undergoing Roux-en-Y Gastric Bypass Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Charcoal, Activated
    • Human Coagulation Factor Ii
    • Human Coagulation Factor Ix
    The Netherlands

  • Study on the Spread of LetibotulinumtoxinA Compared to OnabotulinumtoxinA and AbobotulinumtoxinA in Patients with Moderate to Severe Forehead Wrinkles

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    • Botulinum Toxin Type A
    Germany

  • Study Comparing the Effectiveness and Safety of Botulinum Toxin Type A Products for Treating Frown Lines in Adults

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Skin wrinkling
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    • Botulinum Toxin Type A
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    The Netherlands
Previous Page
1 … 789 790 791 792 793 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!